A Phase 2 Study of Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)

Condition:   Autosomal Recessive Ichthyosis Interventions:   Biological: KB105;   Other: Placebo Sponsor:   Krystal Biotech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials